Nordea Initiates Buy on Biogaia, Target 140 SEK, 15% Upside

Nordea initiated coverage of Biogaia with a buy rating and a 140 SEK target price, implying ~15% upside from Friday's close of 122.1 SEK. This is a single analyst's view, not a consensus shift, and the stock's reaction is uncertain. The move signals modest positive sentiment for the probiotic firm but lacks macro significance.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works